Cytoplasmic p16 Protein in Breast Cancer and Tumor Growth
Author Information
Author(s): R Emig, A Magener, V Ehemann, A Meyer, F Stilgenbauer, M Volkmann, D Wallwiener, H-P Sinn
Primary Institution: Universität Heidelberg
Hypothesis
Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumor proliferation.
Conclusion
Cytoplasmic accumulation of the p16 protein identifies a subset of highly malignant breast carcinomas with accelerated tumor proliferation.
Supporting Evidence
- 33 out of 368 invasive breast cancers showed cytoplasmic p16 expression.
- Median Ki67 index was 70% for tumors with cytoplasmic p16 expression.
- Loss of estrogen and progesterone receptors was common in tumors with p16 overexpression.
Takeaway
Some breast cancer cells have too much of a protein called p16, which makes them grow faster and can be a sign that the cancer is more dangerous.
Methodology
The study evaluated p16 protein expression in breast carcinomas using immunohistochemistry, flow cytometry, and DNA sequencing.
Limitations
The study did not detect genetic alterations in the p16 gene in the analyzed cell lines.
Participant Demographics
The study included 368 invasive breast cancers, 52 non-invasive malignancies, and 88 locally recurring tumors.
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website